Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FWRN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,832
Award facts
- Contract value 100% obligated
- $25,832.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25.8K firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with completion scheduled for October 28, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M comprehensive pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as part of its extensive portfolio of medical product deliveries to military and veteran healthcare systems. The company's DLA Troop Support Medical IDC serves as a global pharmaceutical support mechanism enabling supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's role in supplying specialized pharmaceutical products through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB26FWRN9?
SPE2DB26FWRN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FWRN9 worth?
The government has obligated $25,832 on SPE2DB26FWRN9.
Is contract SPE2DB26FWRN9 an order under another contract?
Yes. SPE2DB26FWRN9 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB26FWRN9 competed?
The extent of competition for SPE2DB26FWRN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award